BioSpace News Archive

Tyme Technologies, Inc. (NASDAQ:TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that the Company will host a conference call and live webcast on Wednesday, May 20, 2020 at 5:00 P.M. ET to report its financial and operating results for its fourth quarter and fiscal year ended March 31, 2020. TYME delivered on multiple major milestones in Fiscal Year 2020, including the h

May 12, 2020 12:13 UTC Abveris Announces Human Antibody Discovery Partnership with Nkarta using the Trianni Mouse ® on the Berkeley Lights Beacon ® CANTON, Mass.--( BUSINESS WIRE )-- Abveris, Inc. (“Abveris”) announced today that it has entered into an antibody discovery partnership with Nkarta, Inc. (“Nkarta”) for the discovery of fully-human monoclonal antibodies to support the advancement of Nkarta’s novel cell-based therapeutics. Under the terms of the agreement, Abveri

Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced that Anthony Johnson, M.D., President and Chief Executive Officer of Goldfinch Bio, will present a company overview at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020 at 2:10 p.m. ET. The presentation will include additional details on

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO, will participate in the UBS Virtual Global Healthcare Conference on Tuesday, May 19 at 10:00 a.m. Eastern Time. The fireside chat will be webcast live

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the U.S. Food and Drug Administration

New website and patient resource will enable adults with Congenital Adrenal Hyperplasia (CAH) to register interest in Spruce’s CAHmelia clinical program, launching later this year SAN FRANCISCO--( BUSINESS WIRE )-- Spruce Biosciences , a late-stage clinical development company focused on developing and commercializing novel therapies for rare endocrine disorders, today announced the launch of CAHstudy.com , a new website and patient resource to enab

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the first quarter ended March 31, 2020, and that it will hold its 2020 annual meeting of stockholders virtually by means of remote communication to help protect the health and safety of employees and s

The global urinary tract infection treatment market is projected to amass a large amount of revenues in the coming years.

In terms of revenue, the multiple sclerosis drugs market is projected to expand at a CAGR of ~6% during the forecast period, due to numerous factors, about which TMR offers comprehensive insights and forecasts in the global multiple sclerosis drugs market report.

According to the report, the global medical talent management IT market was valued at US$ 991.8 Mn in 2019 and is projected to expand at a CAGR of ~10% from 2020 to 2030. Talent management refers to the process of developing, assessing, and identifying a pool of talent that meets the requirements.